| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $2,932,896 ) |
| | 2023 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | R01MH122681 | 2/2 - Identification and Validation of Expression Quantitative Trait Loci (eQTLs) in discrete cell types across human brain development | 001 | 3 | NIH | 8/11/2023 | $413,309 |
| | 2023 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | U01AI165321 | Optimizing the dose of tafenoquine for the radical cure of Plasmodium vivax malaria in Southeast Asia | 000 | 1 | NIH | 9/8/2023 | $1,067,899 |
| | 2023 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | R01MH122681 | 2/2 - Identification and Validation of Expression Quantitative Trait Loci (eQTLs) in discrete cell types across human brain development | 000 | 3 | NIH | 7/17/2023 | $445,168 |
| | 2023 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | U01AA014809 | Defining Translational Approaches for the Image-based Detection of Prenatal Alcohol Exposure | 000 | 20 | NIH | 5/3/2023 | $252,399 |
| | 2023 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | U01AI168655 | Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence | 000 | 2 | NIH | 7/31/2023 | $267,045 |
| | 2023 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | U01AI168655 | Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence | 000 | 2 | NIH | 7/31/2023 | $267,045 |
| | 2023 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | R01MH129751 | 4/4 - The Autism Sequencing Consortium: Discovering autism risk genes and how they impact core features of the disorder | 001 | 2 | NIH | 5/23/2023 | $269,341 |
| | 2023 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 05 | 1 | CDC | 8/14/2023 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OXFORD | University Offices | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 02 | 1 | CDC | 12/23/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OXFORD | University Offices | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 02 | 1 | CDC | 12/23/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 04 | 1 | CDC | 3/10/2023 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 04 | 1 | CDC | 3/10/2023 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OXFORD | University Offices | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 03 | 1 | CDC | 1/12/2023 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OXFORD | University Offices | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 03 | 1 | CDC | 1/12/2023 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OXFORD | University Offices | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 01 | 1 | CDC | 10/24/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OXFORD | University Offices | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 01 | 1 | CDC | 10/24/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 05 | 1 | CDC | 8/14/2023 | $0 |
| | 2023 | 2021 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | F32DC017637 | Structural and functional connectivity markers of developmental speech and language disorders | 001 | 3 | NIH | 11/23/2022 | -$44,436 |
| | 2023 | 2020 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | F32DC017637 | Structural and functional connectivity markers of developmental speech and language disorders | 000 | 2 | NIH | 11/23/2022 | -$363 |
| | 2023 | 2020 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | F32CA239339 | HORMAD1 directs the assembly of a meiotic-Shieldin complex in meiosis and cancer | 000 | 2 | NIH | 11/23/2022 | -$4,510 |
|
| Issue Date FY: 2022 ( Subtotal = $1,266,251 ) |
| | 2022 | 2022 | UNIVERSITY OF OXFORD | University Offices | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 00 | 1 | CDC | 8/19/2022 | $449,989 |
| | 2022 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | U01AI168655 | Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence | 000 | 1 | NIH | 6/17/2022 | $272,913 |
| | 2022 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | U01AI168655 | Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence | 000 | 1 | NIH | 6/17/2022 | $272,912 |
| | 2022 | 2022 | UNIVERSITY OF OXFORD | University Offices | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 00 | 1 | CDC | 8/19/2022 | $200,000 |
| | 2022 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | U01AA014809 | Defining Translational Approaches for the Image-based Detection of Prenatal Alcohol Exposure | 001 | 19 | NIH | 8/15/2022 | $239,399 |
| | 2022 | 2021 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | U01AA014809 | Defining Translational Approaches for the Image-based Detection of Prenatal Alcohol Exposure | 002 | 18 | NIH | 8/17/2022 | $0 |
| | 2022 | 2021 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | U01AA014809 | Defining Translational Approaches for the Image-based Detection of Prenatal Alcohol Exposure | 000 | 18 | NIH | 4/4/2022 | $0 |
| | 2022 | 2021 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | F32DC017637 | Structural and functional connectivity markers of developmental speech and language disorders | 000 | 3 | NIH | 8/3/2022 | -$28,356 |
| | 2022 | 2020 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | R01AI155182 | Exploiting Natural Killer cells in HIV/HBV co-infection to achieve eradication | 000 | 1 | NIH | 3/11/2022 | -$145,467 |
| | 2022 | 2018 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | U01DK105535 | Integrating genome-scale data to reveal causal mechanisms in type 2 diabetes | 001 | 4 | NIH | 9/26/2022 | $4,861 |
|
| Issue Date FY: 2021 ( Subtotal = $790,471 ) |
| | 2021 | 2021 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | U01AA014809 | Defining Translational Approaches for the Image-based Detection of Prenatal Alcohol Exposure | 001 | 18 | NIH | 6/3/2021 | $225,264 |
| | 2021 | 2021 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | F32DC017637 | Structural and functional connectivity markers of developmental speech and language disorders | 000 | 3 | NIH | 3/24/2021 | $72,792 |
| | 2021 | 2021 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | R01DK118297 | Identification of Hypoxia-Inducible Factor-2alpha Activators for Chronic Kidney Disease Anemia | 000 | 5 | NIH | 3/30/2021 | $371,548 |
| | 2021 | 2021 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | R01AI133673 | Maximising Cure Potential in Paediatric HIV Infection | 000 | 5 | NIH | 8/16/2021 | $215,997 |
| | 2021 | 2020 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | U01AA014809 | Defining Translational Approaches for the Image-based Detection of Prenatal Alcohol Exposure | 000 | 17 | NIH | 2/25/2021 | $0 |
| | 2021 | 2020 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | R01AI155182 | Exploiting Natural Killer cells in HIV/HBV co-infection to achieve eradication | 000 | 1 | NIH | 7/6/2021 | $0 |
| | 2021 | 2020 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | F32CA239339 | HORMAD1 directs the assembly of a meiotic-Shieldin complex in meiosis and cancer | 002 | 2 | NIH | 8/16/2021 | $0 |
| | 2021 | 2018 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | F32GM115236 | Imaging nanodomains and lipid rafts in membranes using iSCAT | 000 | 3 | NIH | 12/29/2020 | -$9,624 |
| | 2021 | 2015 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | R01DA030601 | Neural Circuits Underlying Adaptive Behavior and Addiction | 002 | 5 | NIH | 10/3/2020 | -$85,505 |
| | 2021 | 2015 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | R01DA030601 | Neural Circuits Underlying Adaptive Behavior and Addiction | 000 | 5 | NIH | 10/1/2020 | -$85,505 |
| | 2021 | 2015 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | R01DA030601 | Neural Circuits Underlying Adaptive Behavior and Addiction | 001 | 5 | NIH | 10/3/2020 | $85,505 |
|
| Issue Date FY: 2020 ( Subtotal = $1,041,593 ) (Continued on the next page) |
| | 2020 | 2020 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | OX1 2JD | | GBR | U01AA014809 | Defining Translational Approaches for the Image-based Detection of Prenatal Alcohol Exposure | 000 | 17 | NIH | 5/29/2020 | $234,498 |
| | 2020 | 2020 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | OX1 2JD | | GBR | R01AI155182 | Exploiting Natural Killer cells in HIV/HBV co-infection to achieve eradication | 000 | 1 | NIH | 7/9/2020 | $476,070 |
| | 2020 | 2020 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | OX1 2JD | | GBR | F32DC017637 | Structural and functional connectivity markers of developmental speech and language disorders | 000 | 2 | NIH | 2/26/2020 | $69,426 |
| | 2020 | 2020 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | OX1 2JD | | GBR | F32CA239339 | HORMAD1 directs the assembly of a meiotic-Shieldin complex in meiosis and cancer | 001 | 2 | NIH | 9/1/2020 | $11,850 |
| | 2020 | 2020 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | OX1 2JD | | GBR | R01DK118297 | Identification of Hypoxia-Inducible Factor-2alpha Activators for Chronic Kidney Disease Anemia | 000 | 4 | NIH | 3/26/2020 | $351,478 |
|
